Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.64 (
proteinase K
)
4,071
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A novel enzyme activity that catalyzes the degradation of unconjugated bilirubin (Bu) has been demonstrated in extracts of the peels of edible oranges. Unlike the few known bilirubin-oxidizing enzymes, the orange enzyme does not produce biliverdin as a product, does not seem to require oxygen, and has a unique absorption spectrum of its products. Even at the crude stage, the enzyme has a specific activity that is 10 and 20 times higher, respectively, than those reported for the crude or partially purified Bu-degrading enzymes from mushrooms and rat liver. The enzyme has a pH optimum near 7.5 and a Km value of 50-100 microM for Bu. The enzyme is remarkably stable, retaining over 50% activity after prolonged digestion with
proteinase K
or heating at 100 degrees C. Similar treatments inactivated the bilirubin oxidase from Myrothecium verrucaria
MT-1
. The enzyme is poorly soluble in water but can be partially solubilized with cholic acid, with a doubling in specific activity.
...
PMID:A new bilirubin-degrading enzyme from orange peels. 324 68